Pharmacogenomics testing services for personalized medicine in Ireland.
The Health Service Executive (HSE) of Ireland is procuring pharmacogenomics testing services to support personalized medicine initiatives. The scope includes the provision of genetic testing to guide drug therapy decisions for patients, covering a range of medications. The buyer is the HSE, serving the Irish public healthcare system. Requirements include ISO 15189 accreditation or equivalent, experience in pharmacogenomics testing, and compliance with GDPR. The contract is expected to be multi-year with an estimated value between €1 million and €10 million.